Dan Kaufmann

833 total citations
42 papers, 625 citations indexed

About

Dan Kaufmann is a scholar working on Management of Technology and Innovation, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dan Kaufmann has authored 42 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Management of Technology and Innovation, 8 papers in Psychiatry and Mental health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dan Kaufmann's work include Entrepreneurship Studies and Influences (11 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Biotechnology and Related Fields (6 papers). Dan Kaufmann is often cited by papers focused on Entrepreneurship Studies and Influences (11 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Biotechnology and Related Fields (6 papers). Dan Kaufmann collaborates with scholars based in Israel, United States and United Kingdom. Dan Kaufmann's co-authors include Dafna Schwartz, K. C. Brennan, Meir Bialer, Boris Yagen, Marshall Devor, H. Steve White, Rob Wilson, Philip Cooke, Tawfeeq Shekh‐Ahmad and Daniel Shefer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and SHILAP Revista de lepidopterología.

In The Last Decade

Dan Kaufmann

37 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Kaufmann Israel 15 191 137 117 116 112 42 625
G. Douglas Jenkins United States 9 118 0.6× 62 0.5× 17 0.1× 61 0.5× 42 0.4× 9 661
Bo-Hyun Yoon South Korea 16 432 2.3× 40 0.3× 16 0.1× 320 2.8× 66 0.6× 107 1.2k
Markus Lang Switzerland 22 100 0.5× 240 1.8× 25 0.2× 115 1.0× 19 0.2× 119 2.0k
Reshma Shah United States 10 32 0.2× 124 0.9× 51 0.4× 260 2.2× 13 0.1× 13 781
George Tesar United States 17 400 2.1× 49 0.4× 182 1.6× 1.3k 10.9× 209 1.9× 55 2.1k
Jackie Hunter United Kingdom 15 103 0.5× 111 0.8× 32 0.3× 29 0.3× 21 0.2× 27 915
Arshad M. Khan United States 20 15 0.1× 201 1.5× 165 1.4× 186 1.6× 24 0.2× 60 1.6k
Salvador Contreras United States 17 268 1.4× 150 1.1× 15 0.1× 10 0.1× 16 0.1× 42 707
Sha Wang China 14 69 0.4× 49 0.4× 60 0.5× 16 0.1× 9 0.1× 61 743

Countries citing papers authored by Dan Kaufmann

Since Specialization
Citations

This map shows the geographic impact of Dan Kaufmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Kaufmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Kaufmann more than expected).

Fields of papers citing papers by Dan Kaufmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Kaufmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Kaufmann. The network helps show where Dan Kaufmann may publish in the future.

Co-authorship network of co-authors of Dan Kaufmann

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Kaufmann. A scholar is included among the top collaborators of Dan Kaufmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Kaufmann. Dan Kaufmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schlesinger, Naomi & Dan Kaufmann. (2025). Updates in uricase therapy for gout. Current Opinion in Rheumatology. 37(6). 422–429.
2.
Kaufmann, Dan, et al.. (2024). Optimizing gout treatment: A comprehensive review of current and emerging uricosurics. Joint Bone Spine. 92(2). 105826–105826. 4 indexed citations
3.
Schlesinger, Naomi & Dan Kaufmann. (2024). Uricases: reflections on recent developments in the management of challenging gout patients. SHILAP Revista de lepidopterología. 2(6). 461–472.
4.
Kaufmann, Dan, et al.. (2023). Engaging faith-based communities in pro-environmental behavior using soft regulations: The case of single-use plastics. Frontiers in Environmental Science. 10. 2 indexed citations
5.
Kaufmann, Dan, et al.. (2021). Smart specialization: a spontaneous four-step process in the mixed Arab–Jewish region of Haifa and Nazareth. Regional Studies. 56(5). 703–718. 7 indexed citations
6.
Parker, Patrick D., Pratyush Suryavanshi, Marcello Melone, et al.. (2020). Non-canonical glutamate signaling in a genetic model of migraine with aura. Neuron. 109(4). 611–628.e8. 52 indexed citations
7.
Schwartz, Dafna, et al.. (2019). Small businesses are promoting innovation!! Do we know this?. Small Enterprise Research. 26(1). 18–35. 8 indexed citations
8.
Kaufmann, Dan & K. C. Brennan. (2018). The Effects of Chronic Stress on Migraine Relevant Phenotypes in Male Mice. Frontiers in Cellular Neuroscience. 12. 294–294. 27 indexed citations
9.
Xie, Yuanyuan, Dan Kaufmann, Matthew J. Moulton, et al.. (2017). Lef1-dependent hypothalamic neurogenesis inhibits anxiety. PLoS Biology. 15(8). e2002257–e2002257. 21 indexed citations
10.
Kaufmann, Dan, Peter J. West, Misty D. Smith, et al.. (2016). sec -Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory pain. Pharmacological Research. 117. 129–139. 14 indexed citations
11.
Kaufmann, Dan & Miki Malul. (2014). The Dynamic Brain Drain of Entrepreneurs in Peripheral Regions. European Planning Studies. 23(7). 1345–1356. 9 indexed citations
12.
Kaufmann, Dan. (2013). The influence of causation and effectuation logics on targeted policies: the cases of Singapore and Israel. Technology Analysis and Strategic Management. 25(7). 853–870. 11 indexed citations
13.
Pouliot, Wendy A., Meir Bialer, Tawfeeq Shekh‐Ahmad, et al.. (2012). A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus. Neuroscience. 231. 145–156. 29 indexed citations
14.
15.
16.
Kaufmann, Dan, Boris Yagen, Anne Minert, et al.. (2010). Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid. Neuropharmacology. 58(8). 1228–1236. 27 indexed citations
17.
Okada, Akinobu, Yuko Onishi, Boris Yagen, et al.. (2008). Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: Evaluation of the teratogenic effects of its amide derivatives in NMRI mice. Birth Defects Research Part A Clinical and Molecular Teratology. 82(9). 610–621. 5 indexed citations
18.
Kaufmann, Dan, Boris Yagen, Anne Minert, et al.. (2007). Evaluation of the enantioselective antiallodynic and pharmacokinetic profile of propylisopropylacetamide, a chiral isomer of valproic acid amide. Neuropharmacology. 54(4). 699–707. 8 indexed citations
19.
Kaufmann, Dan, Dafna Schwartz, Amnon Frenkel, & Daniel Shefer. (2003). The Role of Location and Regional Networks for Biotechnology Firms in Israel. European Planning Studies. 11(7). 823–840. 30 indexed citations
20.
Berger, Mary Ellen, et al.. (1981). The medical technologist and the radiation-accident victim.. PubMed. 47(10). 829–34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Douglas Jenkins Breakdown of academic impact, for papers by Bo-Hyun Yoon Breakdown of academic impact, for papers by Markus Lang Breakdown of academic impact, for papers by Reshma Shah Breakdown of academic impact, for papers by George Tesar Breakdown of academic impact, for papers by Jackie Hunter Breakdown of academic impact, for papers by Arshad M. Khan Breakdown of academic impact, for papers by Salvador Contreras Breakdown of academic impact, for papers by Sha Wang
Rankless by CCL
2026